BIOMAT Database Logo BIOMAT Database Logo

The clinical pharmacokinetics of phenytoin. 1977

E Martin, and T N Tozer, and L B Sheiner, and S Riegelman

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Clinical pharmacokinetics of phenytoin.
January 1979, Clinical pharmacokinetics,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Phenytoin: pharmacokinetics and clinical therapeutics.
January 1981, Neurosurgery,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Effect of phenytoin on the clinical pharmacokinetics of amiodarone.
December 1990, Journal of clinical pharmacology,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
October 1980, American journal of veterinary research,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Population pharmacokinetics of phenytoin from routine clinical data in Japan.
February 1989, Journal of clinical pharmacy and therapeutics,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Pharmacokinetics and clinical use of parenteral phenytoin, phenobarbital, and paraldehyde.
January 1989, Epilepsia,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Phenytoin: pharmacokinetics and bioavailability.
February 1976, Clinical pharmacology and therapeutics,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Pharmacokinetics of phenytoin in children.
November 1981, British journal of clinical pharmacology,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
The effect of salicylate on phenytoin pharmacokinetics.
January 1979, Transactions of the American Neurological Association,
E Martin, and T N Tozer, and L B Sheiner, and S Riegelman
Phenytoin pharmacokinetics in catamenial epilepsy.
July 1984, Neurology,
Copied contents to your clipboard!